Seizure Disorders Clinical Trials

A listing of Seizure Disorders medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Sage Therapeutics
Birmingham Alabama 35233

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Birmingham Alabama 35233

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Mobile Alabama 36617

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Arizona

Sage Therapeutics
Phoenix Arizona 85013

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Phoenix Arizona 85006

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Arkansas

Sage Therapeutics
Little Rock Arkansas 72202

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

California

Sage Therapeutics
Fresno California 93701

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Loma Linda California 92354

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Los Angeles California 90027

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Roseville California 95661

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Sacramento California 95317

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Connecticut

Sage Therapeutics
New Haven Connecticut 06510

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

District of Columbia

Sage Therapeutics
Washington District of Columbia 20010

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Florida

Sage Therapeutics
Gainesville Florida 32610

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Jacksonville Florida 32209

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Miami Florida 33155

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Orlando Florida 32803

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Sarasota Florida 34239

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Weston Florida 33331

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Georgia

Sage Therapeutics
Atlanta Georgia 30342

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Atlanta Georgia 30322

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Atlanta Georgia 30303

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Atlanta Georgia 30322

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Idaho

Sage Therapeutics
Boise Idaho 83706

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Illinois

Sage Therapeutics
Chicago Illinois 60612

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Chicago Illinois 60611

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Chicago Illinois 60611

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Peoria Illinois 61637

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Springfield Illinois 62702

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Urbana Illinois 61801

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Iowa

Sage Therapeutics
Iowa City Iowa 52242

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Kansas

Sage Therapeutics
Wichita Kansas 67214

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Kentucky

Sage Therapeutics
Lexington Kentucky 40503

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

University of Kentucky Chandler Medical Center
Lexington Kentucky 40536

ESETT Established Status Epilepticus Treatment Trial (ESETT)

Sage Therapeutics
Louisville Kentucky 40202

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Louisiana

Sage Therapeutics
Baton Rouge Louisiana 70808

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
New Orleans Louisiana 70115

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Maine

Sage Therapeutics
Portland Maine 04102

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Maryland

Sage Therapeutics
Baltimore Maryland 21201

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Baltimore Maryland 21215

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Massachusetts

Sage Therapeutics
Boston Massachusetts 02215

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Boston Massachusetts 02111

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Boston Massachusetts 02114

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Boston Massachusetts 02115

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Newton Massachusetts 02462

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Michigan

Sage Therapeutics
Ann Arbor Michigan 48109

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Detroit Michigan 48202

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Detroit Michigan 48201

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
East Lansing Michigan 48824

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus

Sage Therapeutics
Grand Rapids Michigan 49503

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects with Super-Refractory Status Epilepticus